Join PharmaDispatch
Subscribe
Login
Explore the Site
Home
Latest News
BioPharma
Australian Biotech
Other Health
Comment
Executive
'MyBioPharmaSpace'
Video
Podcast
Conference 2019
About
Contact
Subscribe
Search
Follow Us
LinkedIn
Twitter
Instagram
BioPharmaDispatch
Menu
April 23, 2025
Subscribe
Login
Home
Latest News
BioPharma
Australian Biotech
Other Health
Comment
Executive
'MyBioPharmaSpace'
Video
Podcast
Conference 2019
About
Contact
Subscribe
Search
Sign In
Login
Forgot password?
Contact Us
Suite 9214
4 Duff Place
Deakin
ACT
2600
t. 0408 492 937
e.
contact@dailydispatch.com.au
Latest Video
Most Read
'Arguing over the proverbial lifejacket whilst patients are in the water drowning. Shame'
April 22, 2025 - Latest News
Australia increasingly isolated after Europe approves Alzheimer's therapy
April 22, 2025 - BioPharma
Lilly records another win in weight loss in trial of oral GLP-1 agonist
April 22, 2025 - Latest News
FDA removes industry representatives from its advisory committees
April 22, 2025 - Latest News
Pharmac proposes three-monthly quantities for popular asthma inhalers
April 22, 2025 - Latest News
Follow Us
LinkedIn
Twitter
Instagram
New Stories
Mesoblast says Ryoncil payer coverage extended to over 100 million Americans
April 22, 2025 - - Australian Biotech
Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial
April 22, 2025 - - Australian Biotech
Recce Phase 2 trial receives additional approval for treating diabetic patients with topical gel
April 22, 2025 - - Australian Biotech
Race says patient enrolment opened at second site for RC220 solid tumour trial
April 22, 2025 - - Australian Biotech
Neurizon announces the appointment of chief financial officer
April 22, 2025 - - BioPharmaDispatch Executive
Australia increasingly isolated after Europe approves Alzheimer's therapy
April 22, 2025 - - BioPharma
Pharmac proposes three-monthly quantities for popular asthma inhalers
April 22, 2025 - - Latest News